Login

Stephen Streater: CEO of Forbidden Technologies | Stephen Streater , CEO at Forbidden Technologies plc 00:10:00

Share On Facebook Share On Twitter

The CEO of Forbidden Technologies plc is Stephen Streater.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Mchao Resources: Advancing Rare Earth Projects in Malawi with Strong Financial Backing
00:00:00
Respiri - executive interview - Marjan Mikel Chief Executive Officer, Respiri Ltd
00:10:00
Chris Flowers on Financial Crises: Reflections and Future Risks | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
Empowering Progress: Formpipe Software's Q4 2023 Interim Report Presentation and Full Year Achievements | Magnus Svenningson , CEO at Formpipe Software ab
00:10:00
Crystal Peak Minerals: Unlocking Premium SOP Opportunities in Utah
00:10:00
Salazar Resources: Ecuadorian Copper Exploration
00:10:00
Strategic Leadership in Private Equity and Infrastructure - Partner & Chairman of the Global Advisory Board at Campbell Lutyens
00:10:00
4GLOBAL's CEO Eloy Mazon on Leading Big Data Insights and Sports Analytics | Eloy Mazon, CEO, 4GLOBAL PLC.
00:10:00
CSE's Cannabis Market Success and Future Outlook
00:10:00
CEO Alan Trefler positions Pegasystems Inc. strategically for long-term success in customer engagement.
00:10:00
RNC Minerals: Transforming Focus from Nickel to Gold with Strategic Asset Acquisition
00:10:00
Scotiabank CEO Scott Thompson on Strategic Vision and Navigating North American Markets | Scott Thompson, CEO, Scotiabank.

© 2026 Nehu